Arterial versus venous sampling for activated coagulation time measurements during cardiac surgery: A comparative study

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 18, Issue 5, 2004, Pages 573-580

  Leyvi, Galina ^a,b   Zhuravlev, Ilya ^a   Inyang, Asuquo ^a   Vinluan, Joselito ^a   Ramachandran, Sujatha ^a   Lehning, Ellen J ^a   Wasnick, John D ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

activated coagulation time; cardiopulmonary bypass; coagulation; heparin; protamine

Indexed keywords

ETOMIDATE; FENTANYL; HEPARIN; ISOFLURANE; MIDAZOLAM; PANCURONIUM; PROTAMINE;

ADULT; AGED; ANESTHESIA INDUCTION; ARTERIAL BLOOD; ARTERY CATHETER; ARTERY CATHETERIZATION; ARTICLE; BLOOD CLOTTING TIME; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PULMONARY ARTERY; STATISTICAL SIGNIFICANCE; VENOUS BLOOD;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ARTERIES; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CATHETERIZATION, SWAN-GANZ; FEMALE; HEPARIN; HEPARIN ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTAMINES; TIME FACTORS; VEINS; WHOLE BLOOD COAGULATION TIME;

EID: 5644273929     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2004.07.006     Document Type: Article

References (23)

1. Bull B.S., Korpman R.A., Huse W.M., et al. Heparin therapy during extracorporal circulation: 1. Problems inherent in existing heparin protocol. J Thorac Cardiovasc Surg. 68:1975;725-784
2. Young J.A., Kisher C.T., Doty D.T. Adequate anticoagulation during cardiopulmonary bypass determined by activated clotting time and the appearance of fibrin monomer. Ann Thorac Surg. 26:1976;231-234
3. Gravlee G.P., Brauer S.D., Roy R.C., et al. Predicting the pharmacodynamics of heparin A clinical evaluation of the Hepcon System 4. J Cardiothorac Anesth. 1:1987;379-387
4. Zeevi B., Bar-Mor G., Livne M., et al. A comparison of arterial versus venous activated clotting time in patients with congenital heart disease undergoing cardiac catheterization. Catheter Cardiovasc Interv. 46:1999;194-196
5. Pesola G.R., Johnson A., Pesola D.A. Percutaneous transluminal coronary angioplasty comparison of arterial vs. venous activated clotting time. Cathet Cardiovasc Diagn. 37:1996;140-144
6. Warner M.F., Mian M.S., Missri J.C. Activated clotting time variability in patients undergoing coronary angioplasty. Clin Cardiol. 17:1994;372-374
7. Rath B., Bennett D.H. Monitoring the effect of heparin by measurement of activated clotting time during and after percutaneous transluminal coronary angioplasty. Br Heart J. 63:1990;18-21
8. Lew J.K., Hutchinson R., Lin E.S. Intra-arterial blood sampling for clotting studies Effect of heparin contamination. Anaesthesia. 46:1991;719-721
9. Arrants J., Willis M.E., Stevens B., et al. Reliability of an intravenous intermittent access port for obtaining blood samples for coagulation studies. Am J Crit Care. 8:1999;344-348
10. Powers J.M. Obtaining blood samples for coagulation studies from a normal saline lock. Am J Crit Care. 8:1999;250-253
11. Zisman E., Rosenberg B., Katz Y., et al. A comparison between arterial and venous-sampled activated clotting time measurements. Isr J Med Sci. 33:1997;786-788
12. Bland J.M., Altman D.G. Measuring agreement in method comparison studies. Stat Methods Med Res. 8:1999;135-160
13. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 8:1986;307-310
14. Mantha S., Roisen M.F., Fleisher L.A., et al. Comparing methods of clinical measurement Reporting standards for Bland and Altman analysis. Anesth Analg. 90:2000;593-602
15. Moorman R.M., Zapol W.M., Lowenstein E. Neutralization of heparin anticoagulation. Gravlee G.P., Davis R.F., Utley J.R. Cardiopulmonary Bypass Principles and Practice. 1993;381-406 Lippincott Williams & Wilkins, Philadelphia, PA
16. Shore-Lesserson L. Coagulation monitoring. Kaplan J.A., Reich D.L., Konstadt S.N. Cardiac Anesthesia. 1999;507-534 Saunders, Philadelphia, PA
17. Manspeizer H.E., Imai M., Frumento R.J., et al. Arterial and venous thrombelastograph variables differ during cardiac surgery. Anesth Analg. 93:2001;277-281
18. Schuurman P.R., Albrecht K.W. Intraoperative changes of transcranial Doppler velocity Relation to arterial oxygen content and whole-blood viscosity. Ultrasound Med Biol. 25:1999;151-154
19. Macko R.F., Ameriso S.F., Akmal M., et al. Arterial oxygen content and age are determinants of middle cerebral artery blood flow velocity. Stroke. 24:1993;1025-1028
20. Furukawa K., Ushida T., Sugano H., et al. Real time observation of platelet adhesion to opaque biomaterial surfaces under shear flow conditions. J Biomed Mater Res. 46:1999;93-102
21. Frumento R.J., Hirsh A.L., Parides M.K., et al. Differences in arterial and venous thromboelastography parameters Potential roles of shear stress and oxygen content. J Cardiothorac Vasc Anesth. 16:2002;551-554
22. Bode A.P., Eick L. Lysed platelets shorten the activated coagulation time (ACT) of heparinazed blood. Am J Clin Pathol. 91:1989;430-434
23. Bode A.P., Castellani W.J., Hodges E.D., et al. The effect of lysed platelets on neutralization of heparin in vitro with protamine as measured by the activated coagulation time (ACT). Thromb Haem. 66:1991;213-217